Advertisement

Antiphospholipid antibody–associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone

      Abstract

      OBJECTIVE: The purpose of this study was to compare the use of low-dose aspirin alone with heparin and low-dose aspirin in the treatment of the antiphospholipid antibody syndrome. STUDY DESIGN: A prospective, single-center trial included 50 patients who were alternately assigned to treatment. Each patient had at least three consecutive spontaneous pregnancy losses, positive antiphospholipid antibodies on two occasions, and a complete evaluation. Data were compared by χ2 analysis and Fisher's exact test. RESULTS: Viable infants were delivered of 11 of 25 (44%) women treated with aspirin and 20 of 25 (80%) women treated with heparin and aspirin (p < 0.05). There were no significant differences between the low-dose aspirin and the heparin plus low-dose aspirin groups with respect to gestational age at delivery (37.8 ± 2.1 vs 37.2 ± 3.4 weeks), number of cesarean sections (18% vs 20%), or complications. CONCLUSION: Heparin plus low-dose aspirin provides a significantly better pregnancy outcome than low-dose aspirin alone does for antiphospholipid antibody–associated recurrent pregnancy loss. (AM J OBSTET GYNECOL 1996;174:1584-9.)

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kutteh WH
        • Pasquarette M
        Recurrent pregnancy loss.
        in: Advances in obstetrics and gynecology. 2. Mosby–Year Book, St. Louis1995: 147-177
        • Triplett DA
        Antiphospholipid antibodies and recurrent pregnancy loss.
        Am J Reprod Immunol. 1989; 20: 52-67
        • Chamley LW
        • McKay EJ
        • Pattison NS
        Inhibition of heparin/antithrombin III cofactor activity by anticardiolipin antibodies: a mechanism for thrombosis.
        Thromb Res. 1993; 71: 103-111
        • Shibata S
        • Harpel P
        • Bona C
        • Filit H
        Monoclonal antibodies to heparin sulfate inhibit the formation of thrombin-antithrombin III complexes.
        Clin Immunol Immunopathol. 1993; 67: 264-272
        • Rote NS
        Pregnancy-associated immunological disorders.
        Curr Opin Immunol. 1989; 1: 1165-1172
        • Harris EN
        Annotation: antiphospholipid antibodies.
        Br J Haematol. 1990; 74: 1-9
        • Cowchock FS
        • Reece EA
        • Balaban D
        • Branch DW
        • Plouffe L
        Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment.
        AM J OBSTET GYNECOL. 1992; 155: 1318-1323
        • Rosove MH
        • Tabsh K
        • Wasserstrum N
        • Howard P
        • Hahn BH
        • Kalunian KC
        Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies.
        Obstet Gynecol. 1990; 75: 630-634
        • Coulam CB
        • Stern JJ
        • Bustillo M
        Ultrasonographic findings of pregnancy losses after treatment for recurrent pregnancy loss: intravenous immunoglobulin versus placebo.
        Fertil Steril. 1994; 61: 248-251
        • Ermel LD
        • Marshburn PB
        • Kutteh WH
        Interaction of heparin with antiphospholipid antibodies (APA) from the sera of women with recurrent pregnancy loss (RPL).
        Am J Reprod Immunol. 1995; 33: 14-20
        • McIntyre JA
        • Taylor CG
        • Torry DS
        • Wagenknecht DR
        • Wilson J
        • Faulk WP
        Heparin and pregnancy in women with a history of repeated miscarriages.
        Haemostasis. 1993; 23: 202-211
        • Kutteh WH
        • Wester RM
        Multiples of the median: an alternate method for reporting antiphospholipid antibodies in women with recurrent pregnancy loss.
        Obstet Gynecol. 1994; 84: 811-815
        • Dahlman T
        • Sjöberg HE
        • Ringertz H
        Bone mineral density during long-term prophylaxis with heparin in pregnancy.
        AM J OBSTET GYNECOL. 1994; 170: 1315-1320
        • Cunningham FG
        • MacDonald PC
        • Gant NF
        • Leveno KJ
        • Gilstrap LC
        Hypertensive disorders in pregnancy.
        in: 19th ed. Williams' obstetrics. Appleton & Lange, Norwalk, Connecticut1993: 763-817
        • Branch DW
        • Silver RM
        • Blackwell JL
        • Reading JC
        • Scott JR
        Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience.
        Obstet Gynecol. 1992; 80: 614-620
        • Branch DW
        • Rote NS
        • Dostal DA
        • Scott JR
        Association of lupus anticoagulant with antibody against phosphatidylserine.
        Clin Immunol Immunopathol. 1987; 42: 63-75
        • Rote NS
        • Dostal-Johnson DA
        • Branch DW
        Antiphospholipid antibodies and recurrent pregnancy loss: correlation between the activated partial thromboplastin time and antibodies against phosphatidylserine and cardiolipin.
        AM J OBSTET GYNECOL. 1990; 163: 575-584
        • Lockshin MD
        • Druzin ML
        • Qamar T
        Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody.
        AM J OBSTET GYNECOL. 1989; 160: 439-443
        • Hauth JC
        • Goldenberg RL
        • Parker CR
        • Cutter GR
        • Cliver SP
        Low-dose aspirin: lack of association with an increase in abruptio placenta or perinatal mortality.
        Obstet Gynecol. 1995; 85: 1055-1058
        • Branch DW
        • Scott JR
        Clinical implication of antiphospholipid antibodies: the Utah experience.
        in: Phospholipid-binding antibodies. CRC, Boca Raton, Florida1990: 355-1346
        • Laufer MR
        • Ecker JC
        • Hill JA
        Pregnancy outcome following ultrasound-detected fetal cardiac activity in women with a history of multiple spontaneous abortions.
        J Soc Gynecol Invest. 1994; 1: 138-142